Prepare for More Insulin Biosimilars
January 2023
Kirsty (insulin aspart) and Semglee (insulin glargine 100 units/mL) will be the latest insulin biosimilars to hit your pharmacy fridges.
Follow your provincial laws if payers require a switch. These biosimilars usually can’t be automatically substituted.
That’s because biosimilars aren’t generics. It’s not possible to create an exact copy of the original “reference” biologic...since biologics are made from living organisms and are complex molecules.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive